Answer
The safety and efficacy of Velcade (bortezomib) have not been established in children under 18, and no dosing recommendation can be made.
Sources for this answer
- Velcade 3.5mg powder for solution for injection (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.2 Posology and method of administration · Version 37Document updated
Sources checked